C Ann Merrifield Lyra Therapeutics, Inc. (LYRA) insider trading activity

LYRA Quotes by TradingView

C Ann Merrifield is of Lyra Therapeutics, Inc.. Currently has a direct ownership of 11,328 shares of LYRA, which is worth approximately $2,832. The most recent transaction as insider was on Jun 10, 2022, when has been sold 4,000 shares (Common Stock) at a price of $5.05 per share, resulting in proceeds of $20,200. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 11.3K
0% 3M change
0% 12M change
Total Value Held $2,832

C ANN MERRIFIELD Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 10 2022
BUY
Open market or private purchase
$20,200 $5.05 p/Share
4,000 Added 26.1%
11,328 Common Stock
May 16 2022
BUY
Open market or private purchase
$1,640 $5.0 p/Share
328 Added 4.28%
7,328 Common Stock
May 13 2022
BUY
Open market or private purchase
$16,835 $4.81 p/Share
3,500 Added 33.33%
7,000 Common Stock
Jun 17 2021
BUY
Open market or private purchase
$31,395 $8.97 p/Share
3,500 Added 50.0%
3,500 Common Stock

Also insider at

NVIV
INVIVO THERAPEUTICS HOLDINGS CORP. Healthcare
Director
FLXN
Flexion Therapeutics Inc
Director
CAM

C Ann Merrifield

Cambridge, MA

Track Institutional and Insider Activities on LYRA

Follow Lyra Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LYRA shares.

Notify only if

Insider Trading

Get notified when an Lyra Therapeutics, Inc. insider buys or sells LYRA shares.

Notify only if

News

Receive news related to Lyra Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on LYRA